97 reports of this reaction
1.4% of all PHENYTOIN SODIUM reports
#17 most reported adverse reaction
STATUS EPILEPTICUS is the #17 most commonly reported adverse reaction for PHENYTOIN SODIUM, manufactured by Mylan Pharmaceuticals Inc.. There are 97 FDA adverse event reports linking PHENYTOIN SODIUM to STATUS EPILEPTICUS. This represents approximately 1.4% of all 6,984 adverse event reports for this drug.
Patients taking PHENYTOIN SODIUM who experience status epilepticus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
STATUS EPILEPTICUS is a less commonly reported adverse event for PHENYTOIN SODIUM, but still significant enough to appear in the safety profile.
In addition to status epilepticus, the following adverse reactions have been reported for PHENYTOIN SODIUM:
The following drugs have also been linked to status epilepticus in FDA adverse event reports:
STATUS EPILEPTICUS has been reported as an adverse event in 97 FDA reports for PHENYTOIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
STATUS EPILEPTICUS accounts for approximately 1.4% of all adverse event reports for PHENYTOIN SODIUM, making it a notable side effect.
If you experience status epilepticus while taking PHENYTOIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.